Triastek's 3D printed non-vitamin K antagonist oral anticoagulant (NOAC) T20G has received FDA IND clearance, following earlier approval from China's NMPA in January 2024.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.